These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31761524)

  • 1. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
    Rekhi G; Alphs L; Ang MS; Lee J
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Chinese Version of the 16-Item Negative Symptom Assessment.
    Huang BJ; Wang Y; Miao Q; Yu X; Pu CC; Shi C
    Neuropsychiatr Dis Treat; 2020; 16():1113-1120. PubMed ID: 32440125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.
    Garcia-Alvarez L; Garcia-Portilla MP; Saiz PA; Fonseca-Pedrero E; Bobes-Bascaran MT; Gomar J; Muñiz J; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(3):169-175. PubMed ID: 29628403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Vayisoğlu S; Karahan S; Gürel ŞC; Yağcioğlu AEA
    Noro Psikiyatr Ars; 2024; 61(1):59-65. PubMed ID: 38496217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Brief Negative Symptom Scale and its association with functioning.
    Ang MS; Rekhi G; Lee J
    Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
    Rostami R; Kazemi R; Khodaie-Ardakani MR; Sohrabi L; Ghiasi S; Sadat Kamali Z; Zaryabi A; Ghiasi Z; Nasiri Z; Rezaei M; Addington DE
    Asian J Psychiatr; 2019 Oct; 45():44-49. PubMed ID: 31493624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a 4-item Negative Symptom Assessment (NSA-4): a short, practical clinical tool for the assessment of negative symptoms in schizophrenia.
    Alphs L; Morlock R; Coon C; Cazorla P; Szegedi A; Panagides J
    Int J Methods Psychiatr Res; 2011 Jun; 20(2):e31-7. PubMed ID: 21538654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
    Sarró S; Dueñas RM; Ramírez N; Arranz B; Martínez R; Sánchez JM; González JM; Saló L; Miralles L; San L
    Schizophr Res; 2004 Jun; 68(2-3):349-56. PubMed ID: 15099616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.
    Grover S; Sahoo S; Dua D; Chakrabarti S; Avasthi A
    Psychiatry Res; 2017 Jun; 252():333-339. PubMed ID: 28315621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Turkish version of brief negative symptom scale.
    Polat Nazlı I; Ergül C; Aydemir Ö; Chandhoke S; Üçok A; Gönül AS
    Int J Psychiatry Clin Pract; 2016 Nov; 20(4):265-71. PubMed ID: 27409157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Engel M; Fritzsche A; Lincoln TM
    Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Korean-Version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS).
    Jung SI; Woo J; Kim YT; Kwak SG
    J Korean Med Sci; 2016 Jul; 31(7):1114-20. PubMed ID: 27366011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Danish version of the brief negative symptom scale.
    Gehr J; Glenthøj B; Ødegaard Nielsen M
    Nord J Psychiatry; 2019 Oct; 73(7):425-432. PubMed ID: 31407936
    [No Abstract]   [Full Text] [Related]  

  • 16. The Greek version of the calgary depression scale for schizophrenia.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Margariti MM; Stamouli SS; Kollias CT; Angelopoulos EK; Christodoulou GN
    Psychiatry Res; 2000 May; 94(2):163-71. PubMed ID: 10808041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).
    Lançon C; Auquier P; Reine G; Bernard D; Toumi M
    J Affect Disord; 2000 May; 58(2):107-15. PubMed ID: 10781700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.
    Rabany L; Weiser M; Werbeloff N; Levkovitz Y
    Schizophr Res; 2011 Mar; 126(1-3):226-30. PubMed ID: 21115328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
    Goldring A; Borne S; Hefner A; Thanju A; Khan A; Lindenmayer JP
    Schizophr Res; 2020 Oct; 224():159-166. PubMed ID: 33071071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools to assess negative symptoms in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2013 Jun; 74(6):e12. PubMed ID: 23842020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.